i-SENS Inc - Asset Resilience Ratio
i-SENS Inc (099190) has an Asset Resilience Ratio of 6.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read i-SENS Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how i-SENS Inc's Asset Resilience Ratio has changed over time. See i-SENS Inc shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down i-SENS Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see i-SENS Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩35.99 Billion | 6.17% |
| Total Liquid Assets | ₩35.99 Billion | 6.17% |
Asset Resilience Insights
- Limited Liquidity: i-SENS Inc maintains only 6.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
i-SENS Inc Industry Peers by Asset Resilience Ratio
Compare i-SENS Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Elbit Med Tech
TA:EMTC |
Healthcare Equipment & Supplies | 7.83% |
|
InBody Co.Ltd
KQ:041830 |
Healthcare Equipment & Supplies | 20.98% |
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 9.67% |
|
Meta Biomed Co. Ltd
KQ:059210 |
Healthcare Equipment & Supplies | 11.86% |
|
MEKICS Co Ltd
KQ:058110 |
Healthcare Equipment & Supplies | 5.91% |
Annual Asset Resilience Ratio for i-SENS Inc (2012–2024)
The table below shows the annual Asset Resilience Ratio data for i-SENS Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 20.16% | ₩119.13 Billion ≈ $80.73 Million |
₩590.87 Billion ≈ $400.42 Million |
+9.76pp |
| 2023-12-31 | 10.40% | ₩51.87 Billion ≈ $35.15 Million |
₩498.82 Billion ≈ $338.04 Million |
-5.73pp |
| 2022-12-31 | 16.13% | ₩72.51 Billion ≈ $49.14 Million |
₩449.57 Billion ≈ $304.67 Million |
-7.33pp |
| 2021-12-31 | 23.45% | ₩100.66 Billion ≈ $68.22 Million |
₩429.18 Billion ≈ $290.85 Million |
-3.07pp |
| 2020-12-31 | 26.52% | ₩81.43 Billion ≈ $55.19 Million |
₩307.03 Billion ≈ $208.07 Million |
+9.35pp |
| 2019-12-31 | 17.18% | ₩46.38 Billion ≈ $31.43 Million |
₩270.04 Billion ≈ $183.00 Million |
+6.06pp |
| 2018-12-31 | 11.11% | ₩28.01 Billion ≈ $18.98 Million |
₩252.05 Billion ≈ $170.81 Million |
-0.83pp |
| 2017-12-31 | 11.95% | ₩27.96 Billion ≈ $18.95 Million |
₩234.08 Billion ≈ $158.63 Million |
-0.93pp |
| 2016-12-31 | 12.88% | ₩27.70 Billion ≈ $18.77 Million |
₩215.07 Billion ≈ $145.75 Million |
+9.54pp |
| 2015-12-31 | 3.34% | ₩6.00 Billion ≈ $4.07 Million |
₩179.80 Billion ≈ $121.85 Million |
+1.94pp |
| 2014-12-31 | 1.40% | ₩2.28 Billion ≈ $1.55 Million |
₩163.51 Billion ≈ $110.81 Million |
-3.88pp |
| 2013-12-31 | 5.28% | ₩7.46 Billion ≈ $5.06 Million |
₩141.41 Billion ≈ $95.83 Million |
+3.80pp |
| 2012-12-31 | 1.48% | ₩1.36 Billion ≈ $920.79K |
₩92.05 Billion ≈ $62.38 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more